Bayer Ag Stock Price Prediction
| BAYZF Stock | USD 29.90 1.78 5.62% |
Oversold Vs Overbought
67
Oversold | Overbought |
Using Bayer AG hype-based prediction, you can estimate the value of Bayer AG from the perspective of Bayer AG response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Bayer AG to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Bayer because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Bayer AG after-hype prediction price | USD 29.9 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Bayer |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bayer AG's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bayer AG After-Hype Price Prediction Density Analysis
As far as predicting the price of Bayer AG at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Bayer AG or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Bayer AG, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Bayer AG Estimiated After-Hype Price Volatility
In the context of predicting Bayer AG's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Bayer AG's historical news coverage. Bayer AG's after-hype downside and upside margins for the prediction period are 27.62 and 32.18, respectively. We have considered Bayer AG's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Bayer AG is very steady at this time. Analysis and calculation of next after-hype price of Bayer AG is based on 3 months time horizon.
Bayer AG Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Bayer AG is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bayer AG backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Bayer AG, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.14 | 2.28 | 0.00 | 0.02 | 0 Events / Month | 4 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
29.90 | 29.90 | 0.00 |
|
Bayer AG Hype Timeline
Bayer AG is currently traded for 29.90. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.02. Bayer is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.14%. %. The volatility of related hype on Bayer AG is about 1287.1%, with the expected price after the next announcement by competition of 29.88. About 47.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.36. Some equities with similar Price to Book (P/B) outperform the market in the long run. Bayer AG has Price/Earnings To Growth (PEG) ratio of 1.31. The entity recorded earning per share (EPS) of 5.13. The firm last dividend was issued on the 2nd of May 2022. Bayer AG had 503:495 split on the 6th of June 2018. Assuming the 90 days horizon the next forecasted press release will be in 5 to 10 days. Check out Bayer AG Basic Forecasting Models to cross-verify your projections.Bayer AG Related Hype Analysis
Having access to credible news sources related to Bayer AG's direct competition is more important than ever and may enhance your ability to predict Bayer AG's future price movements. Getting to know how Bayer AG's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Bayer AG may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| RHHBY | Roche Holding Ltd | 0.00 | 0 per month | 1.70 | 0.06 | 2.65 | (2.95) | 13.54 | |
| SNY | Sanofi ADR | (0.64) | 8 per month | 0.98 | 0.16 | 2.68 | (2.12) | 7.28 | |
| GRFS | Grifols SA ADR | (0.19) | 9 per month | 2.58 | 0.07 | 6.68 | (4.39) | 26.13 | |
| NVS | Novartis AG ADR | 0.30 | 9 per month | 1.19 | 0.03 | 1.48 | (1.98) | 5.74 | |
| AZN | AstraZeneca PLC ADR | (0.80) | 7 per month | 0.00 | (0.10) | 1.64 | (2.17) | 5.79 | |
| GSK | GlaxoSmithKline PLC ADR | 0.32 | 11 per month | 1.27 | (0.02) | 2.15 | (2.51) | 6.34 | |
| MRK | Merck Company | (0.23) | 8 per month | 0.00 | (0.12) | 2.01 | (2.09) | 13.12 |
Bayer AG Additional Predictive Modules
Most predictive techniques to examine Bayer price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bayer using various technical indicators. When you analyze Bayer charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Bayer AG Predictive Indicators
The successful prediction of Bayer AG stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Bayer AG, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Bayer AG based on analysis of Bayer AG hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Bayer AG's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Bayer AG's related companies.
Story Coverage note for Bayer AG
The number of cover stories for Bayer AG depends on current market conditions and Bayer AG's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Bayer AG is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Bayer AG's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Bayer AG Short Properties
Bayer AG's future price predictability will typically decrease when Bayer AG's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Bayer AG often depends not only on the future outlook of the potential Bayer AG's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bayer AG's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 982.4 M |
Complementary Tools for Bayer Pink Sheet analysis
When running Bayer AG's price analysis, check to measure Bayer AG's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bayer AG is operating at the current time. Most of Bayer AG's value examination focuses on studying past and present price action to predict the probability of Bayer AG's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bayer AG's price. Additionally, you may evaluate how the addition of Bayer AG to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |